CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Oscotec Incorporation Company Snapshot
Oscotec Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oscotec Incorporation with three other companies in this sector in South Korea: Optipharm Co Ltd (2018 sales of 13.96 billion Korean Won [US$11.66 million] of which 47% was Livestock Medicine), Chem Tech Research Inc (20.54 billion Korean Won [US$17.15 million] of which 26% was OTC entrusted), and iNtRON Biotechnology Inc (20.58 billion Korean Won [US$17.19 million] of which 55% was Technology Export).

Sales Analysis. Sales increased substantially in 2018: During the year ended December of 2018, sales at Oscotec Incorporation were 18.70 billion Korean Won (US$15.62 million). This is an increase of 378.5% versus 2017, when the company's sales were 3.91 billion Korean Won. Sales of Other Segment saw an increase of 379.1% in 2018, from 3.06 billion Korean Won to 14.66 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Oscotec Incorporation
  Stock Performance Chart for Oscotec Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (10/4/2019): 18,950
(Figures in Korean Won)
1 Week 0.0%   13 Weeks 7.1%  
4 Weeks -12.1%   52 Weeks -17.6%  
 
Oscotec Incorporation Key Data:
  Ticker: 039200 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 18,702,671,511
(Year Ending Jan 2019).
Employees: 35
  Currency: Korean Won Market Cap: 532,529,849,050
  Fiscal Yr Ends: December Shares Outstanding: 28,101,839
  Share Type: Common Closely Held Shares: 7,730,920
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.